Articles by Daniel Marsh
AMD Shares Fall Ahead of Nvidia Earnings as Yields Rise
AMD shares dropped 1.6% as investors trimmed chip holdings before Nvidia's earnings and rising yields pressured tech stocks. Citi hiked its AMD price target to $460.
Blue Bird Shares Slide 9.6% on Pension Settlement Charge
Blue Bird Corp. shares dropped 9.6% to $65.75 following an SEC filing that revealed a material non-cash pension settlement charge for the fiscal third quarter.
Thunderstorms Ground Over 350 Flights at American Airlines' DFW Hub
Severe storms at Dallas-Fort Worth International Airport led to an FAA ground stop, resulting in 359 flight cancellations and 452 delays, impacting American Airlines' primary hub and nationwide travel.
Enbridge Shares Hit New High Despite Line 5 Permit Hurdle
Enbridge shares climbed to a 52-week high on Tuesday, advancing 2.76% to C$78.25, as investors focused on reaffirmed 2026 guidance and overlooked a partial construction halt on the Line 5 pipeline in Wisconsin.
Amazon Shares Slip as $200B AI Spending Spree Raises Investor Concerns
Amazon shares fell 2.3% on Tuesday as heavy AI spending weighs on free cash flow, despite AWS revenue surging 28% to $37.6 billion. Analysts remain positive but caution on capital expenditure.
Recursion Pharmaceuticals Hits New Low Amid Revenue Drop and FDA Watch
Recursion Pharmaceuticals shares fell to a 52-week low Tuesday after Q1 revenue dropped 56% year-over-year. The AI-driven biotech firm awaits FDA feedback on key trials.
Yield Surge Reshapes Stock Picks: Nvidia, Dell, ServiceNow, Home Depot in Focus
U.S. stocks declined Tuesday as the 10-year Treasury yield reached its highest since January 2025, pressuring growth shares. Selective buying focused on Nvidia, Dell, ServiceNow, and Home Depot.
Kroger Stock Climbs as CEO Focuses on Price Strategy
Kroger shares gained 3.8% in midday trading Tuesday, outpacing Walmart and Costco, as investors focus on new CEO Greg Foran's pricing strategy.
Co-Diagnostics Stock Skyrockets on Ebola Test Strategy, But Financial Concerns Loom
Co-Diagnostics shares jumped 51% on news of an Ebola assay strategy, but the test awaits regulatory approval and the company faces financial stability concerns.
InMed Shares Surge 109% on $290M Migraine Deal with Mentari
InMed Pharmaceuticals shares surged 108.6% to $1.42 after announcing an all-stock merger with Mentari Therapeutics, backed by a $290 million private placement, pivoting to migraine prevention.